Rishi Raj

Athletes and bodybuilders use anabolic-androgenic steroids (AAS) to increase muscle mass and enhance performance. Its use is widespread among competitive athletes in order to enhance athletic performances. However, the use of AAS has been linked to many deleterious adverse effects, including cardiomyopathy and polycythemia. We present the case of a young man in his late 20s who presented with uncontrolled hypertension and elevated hemoglobin. He was found to have a reduced left ventricular ejection fraction of 20-25%. Further workup showed dilated cardiomyopathy and low normal erythropoietin (EPO) levels. Evaluation for polycythemia vera was negative, and there was no evidence of ischemic cardiomyopathy. The patient later admitted to using injected AAS for professional bodybuilding. The coexistence of both these conditions can be challenging to diagnose and treat. While primary and secondary polycythemia can lead to hyperviscosity and result in ischemic cardiomyopathy from coronary occlusion, anabolic steroids can directly result in cardiomyopathy and polycythemia. This case points to the importance of identifying cardiomyopathy and polycythemia from illicit drug use, which can often be missed, and the workups needed to identify the etiology.

Regulations already in place, fresh laws not needed: Officials

$6.49-bn phones shipped from India in April-July.

As the parliamentary system of government becomes more prime ministerial in nature, the Cabinet secretary has lost much of its powers

Apple has begun negotiations with Micron, the Tata Group and other chip manufacturers setting up plants in India for sourcing supplies worth $12 billion for the iPhones it produces in the country.

The aim of the DCB is to put in place an ex-ante regulatory framework to prevent any anti-competitive conduct by large digital enterprises.

While he failed in steering telecom services successfully despite an early mover advantage, the enterprise business carries on

While he failed in steering telecom services successfully despite an early mover advantage, the enterprise business carries on

Before the PLI scheme was announced in FY19, India exported merely $5.23 million worth of smartphones to the US, making it the 23rd largest export from India to the US.

According to industry sources, smartphone exports reached Rs 1.10 lakh crore in the April-November period, which is 45% higher than the export figure of Rs 76,221 crore for the corresponding period in FY24.